Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011

Description:

Aarkstore.com announce a new report "Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011" through its vast collection of market research report. – PowerPoint PPT presentation

Number of Views:179

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011


1
Aarkstore.com Breast Cancer Vaccines and
Therapeutic Antibodies Pipeline, 2011
2
Summary
  • The breast cancer immunotherapy pipeline is
    showing rapid development. This report presents
    findings on more than 30 candidate therapies,
    including 22 therapeutic vaccines and 11
    antibodies. Of the 22 vaccines in development, 7
    (32) are at clinical phases II III. Drugs
    used to treat breast cancer fall into three main
    groups hormonal blockers, chemotherapeutic
    agents and targeted antibodies. While these
    provide important treatment options for patients,
    their limitations (drug resistance, poor efficacy
    and side effects) have focused efforts on
    developing safer and more effective targeted
    therapies. Currently, the greatest growth in this
    field is in the development of breast cancer
    immunotherapies therapeutic vaccines and
    antibodies. This report presents a
    comprehensive review of the breast cancer
    immunotherapy pipeline, covering new candidate
    vaccines and antibodies. Currently, there are
    more than 20 candidate breast cancer vaccines in
    the pipeline. These include selective candidates,
    developed to target breast cancer and others,
    that are being evaluated against a number of
    cancer types, including breast cancer. This
    report also covers current developments on 11
    antibodies, some of which are new molecules
    developed to selectively target breast cancer and
    others, that are being evaluated for a number of
    cancers, including breast cancer.

3
Table of Contents
  • Report ContentsDue to the nature of this
    report, details (name of candidate vaccine or
    therapeutic antibody, together with their
    respective antigen or target) in this report
    contents page, have been omitted. Executive
    SummaryChapter 1 Background p.7 1. Breast
    Cancer1.1 Statistics1.2 Diagnosis1.3
    Staging1.4 Current Treatments1.5 This
    ReportChapter 2 Breast Cancer Immunotherapy
    Strategies p.12 2.1 Vaccines Antibodies

4
More Related Reports
  •   VEGF Inhibition Therapy-Indicating and
    Prognostic Biomarkers, 2011
  •   Biomarkers in Alzheimers Disease, 2011
  •   Alzheimers Disease Autoantibodies, Vaccines
    and Therapeutic Antibodies Pipeline, 2011
  •   Prostate Cancer Vaccines and Therapeutic
    Antibodies Pipeline, 2011
  •   Breast Cancer Vaccines and Therapeutic
    Antibodies Pipeline, 2011
  •   Alzheimers Disease Biomarkers in Cerebrospinal
    Fluid and Blood, 2011
  •   Image-Based Biomarkers in Alzheimers Disease,
    2011
  •   Lung Cancer Vaccines and Therapeutic
    Antibodies Pipeline, Strategies and Clinical

5
For More details
  • http//www.aarkstore.com/reports/Breast-Cancer-Vac
    cines-and-Therapeutic-Antibodies-Pipeline-2011-146
    442.html
  • Vina
  • Aarkstore.com
  • Contact Marketing team
  • Mob.No.918149852585
  • Email enquiry_at_aarkstore.com
  • URL http//www.aarkstore.com/
  • XML http//www.aarkstore.com/feeds/Biopharmrepor
    ts.xml
About PowerShow.com